World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
53
Citations
10024
World Ranking
3983
National Ranking
155

Overview

Pilar Barrera is affiliated with Radboud University Nijmegen Medical Centre in the Netherlands. Their research primarily focuses on medical sciences, with a particular emphasis on hepatology, epidemiology, surgery, oncology, and pathology and forensic medicine.

The scientist's work features multiple topics related to liver diseases, including:

  • Liver Disease and Transplantation
  • Liver Disease Diagnosis and Treatment
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Hepatitis B Virus Studies
  • Hepatitis C Virus Research
  • Organ Transplantation Techniques and Outcomes
  • Cancer Cells and Metastasis

Frequent publication venues in which Barrera has contributed include:

  • Journal of Hepatology
  • Gastroenterología y Hepatología
  • International Journal of Molecular Sciences
  • Journal of Translational Medicine
  • Nefrología

Barrera has collaborated extensively with several coauthors, notably:

  • Manuel Rodríguez-Perálvarez
  • Manuel de la Mata
  • J.L. Montero
  • Antonio Poyato González
  • Javier Zamora

Some recent papers published by Barrera include:

  • Enumeration and Characterization of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization (2023, International Journal of Molecular Sciences)
  • Early release of circulating tumor cells after transarterial chemoembolization hinders therapeutic response in patients with hepatocellular carcinoma (2025, Journal of Translational Medicine)
  • Profilaxis y tratamiento de la infección por virus de la hepatitis B en el trasplante hepático. VII Documento de consenso de la Sociedad Española de Trasplante Hepático (2020, Gastroenterología y Hepatología)
  • Inflammatory pseudotumor-like follicular dendritic cell sarcoma of the liver (2020, Revista Española de Enfermedades Digestivas)
  • Current status of hepatitis delta in Andalusia: multicenter study (2023, Journal of Hepatology)

Best Publications

  • A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C.

    Bruno Sangro;Carlos Gomez-Martin;Manuel de la Mata;Mercedes Iñarrairaegui

  • New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study

    François Cornélis;Sabine Fauré;Maria Martinez;Jean-François Prud’homme

  • Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages

    E R Vossenaar;T R D Radstake;A van der Heijden;M A M van Mansum

  • Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma.

    Timothy R D J Radstake;Mieke F Roelofs;Yvonne M Jenniskens;Birgitte Oppers-Walgreen

  • IL-32, a proinflammatory cytokine in rheumatoid arthritis.

    Leo A. B. Joosten;Mihai G. Netea;Soo-Hyun Kim;Do-Young Yoon

  • Synovial macrophage depletion with clodronate-containing liposomes in rheumatoid arthritis

    Pilar Barrera;Arjen Blom;Peter L. E. M. Van Lent;Louis Van Bloois

  • Novel association in chromosome 4q27 region with rheumatoid arthritis and confirmation of type 1 diabetes point to a general risk locus for autoimmune diseases.

    Alexandra Zhernakova;Behrooz Z. Alizadeh;Behrooz Z. Alizadeh;Marianna Bevova;Miek A. van Leeuwen

  • Long term anti-tumour necrosis factor alpha monotherapy in rheumatoid arthritis: effect on radiological course and prognostic value of markers of cartilage turnover and endothelial activation

    A A den Broeder;L A B Joosten;Tore Saxne;Dick Heinegård

  • Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis

    C Popa;M G Netea;T R D S Radstake;P L van Riel

  • Circulating soluble tumor necrosis factor receptors, interleukin‐2 receptors, tumor necrosis factor α, and interleukin‐6 levels in rheumatoid arthritis.

    Pilar Barrera;Agnes M. Th. Boerbooms;Elly M. Janssen;Robert W. Sauerwein

  • Successful treatment of dermatomyositis and polymyositis with anti-tumor-necrosis-factor-alpha: preliminary observations.

    G.J.D. Hengstman;F.H.J. van den Hoogen;P. Barrera;M.G. Netea

  • Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis

    Calin Popa;Frank H J van den Hoogen;Timothy R D J Radstake;Mihai G Netea

  • Effects of treatment with a fully human anti-tumour necrosis factor alpha monoclonal antibody on the local and systemic homeostasis of interleukin 1 and TNFalpha in patients with rheumatoid arthritis.

    P Barrera;L A B Joosten;A A den Broeder;L B A van de Putte

  • The Toll-like receptor 4 Asp299Gly functional variant is associated with decreased rheumatoid arthritis disease susceptibility but does not influence disease severity and/or outcome.

    Timothy R. D. J. Radstake;Barbara Franke;Suzanne Hanssen;Mihai G. Netea

  • Common and different genetic background for rheumatoid arthritis and coeliac disease

    Marieke J.H. Coenen;Gosia Trynka;Sandra Heskamp;Barbara Franke

  • Methotrexate-related pulmonary complications in rheumatoid arthritis.

    P. Barrera;R. F. J. M. Laan;P. L. C. M. Van Riel;P. N. R. Dekhuijzen

  • Salmonella septicemia in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: association with decreased interferon-gamma production and Toll-like receptor 4 expression.

    Mihai G. Netea;Timothy Radstake;Leo A. Joosten;Jos W. M. van der Meer

  • Association of interleukin-18 expression with enhanced levels of both interleukin-1beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis.

    Leo A B Joosten;Timothy R D Radstake;Erik Lubberts;Liduine A M van den Bersselaar

  • Differential association of the PTPN22 coding variant with autoimmune diseases in a Dutch population.

    A Zhernakova;P Eerligh;C Wijmenga;P Barrera

  • Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients

    C Popa;L J H van Tits;P Barrera;H L M Lemmers

Frequent Co-Authors

Timothy R D J Radstake
Timothy R D J Radstake Utrecht University
L. B. A. Van De Putte
L. B. A. Van De Putte Radboud University
P.L.C.M. van Riel
P.L.C.M. van Riel Radboud University
Alejandro Balsa
Alejandro Balsa Hospital Universitario La Paz
Barbara Franke
Barbara Franke Radboud University
Paola Migliorini
Paola Migliorini University of Pisa
Mihai G. Netea
Mihai G. Netea Radboud University
Bobby P.C. Koeleman
Bobby P.C. Koeleman Utrecht University
Leo A. B. Joosten
Leo A. B. Joosten Radboud University
Carl G. Figdor
Carl G. Figdor Radboud University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their knowledge beyond Immunology, various online degrees offer flexible options to advance careers in healthcare. Many students explore programs like easy LPN programs to get into. These provide a streamlined path for becoming a Licensed Practical Nurse, a critical role in patient care.

Building on that foundation, easiest nurse practitioner degree programs provide accessible routes to higher qualifications. These programs are designed with flexible schedules and accommodating admission criteria, helping students achieve advanced clinical roles.

For those specializing in mental health, the best online PMHNP programs offer excellent clinical placement opportunities. Quality clinical experience is crucial for Psychiatric Mental Health Nurse Practitioners to gain hands-on skills in diverse settings.

Cost is often a concern, making cheap psych NP programs highly appealing. These affordable options allow students to pursue specialized psychiatric nursing without a heavy financial burden.

Exploring these related pathways can provide valuable career opportunities while complementing a foundation in Immunology.

Best Scientists Citing Pilar Barrera

Recently Published Articles